Advancing CAPA in Life Sciences for Better Quality and Compliance
CAPA in life sciences is one of the most critical systems for ensuring product quality, patient safety, and regulatory compliance. It is also one of the most common sources of audit findings across pharmaceutical, biologics, and medical device organizations. Despite mature quality systems and strict regulatory oversight, many companies continue to face recurring deviations, delayed […]
AI in Aerospace Quality: Practical Next Steps for Aerospace Leaders
By Michael Guymon, President and CEO, SQA ServicesPresented at ASQ Collaboration on Quality in the Space & Defense Industries Forum The Industry Is Moving, With or Without You AI in aerospace quality is no longer a future concept. It is actively reshaping how aerospace and defense organizations design, manufacture, and control complex systems. The question […]
SQA Regulatory Surveillance Summary | 3Q/4Q 2025
Staying informed on the latest pharmaceutical compliance updates is essential for navigating an increasingly complex global regulatory landscape. From evolving GMP requirements and regulatory guidance to enforcement actions and emerging risks, these updates directly impact how organizations manage quality, ensure compliance, and protect patient safety. This summary highlights key developments across major health authorities and […]
Meet SQA at PDA Week 2026
SQA Services is excited to announce our participation in PDA Week 2026, a premier event for leaders across pharmaceutical manufacturing, taking place March 22–27 in Denver, Colorado. PDA Week brings together quality, manufacturing, and regulatory professionals to address the evolving challenges facing the life sciences industry, from compliance and supplier oversight to innovation and operational […]
WEBINAR: Why Aerospace Pre-Production Fails & Building Firefighting into Programs
Watch the Webinar on Aerospace Pre-Production Fails Many of the most costly disruptions in aerospace and defense programs do not begin on the production floor. They begin much earlier during aerospace pre-production. When activities like contract review, supplier readiness verification, and First Article Inspection (FAI) planning are treated as administrative steps rather than operational quality […]
SQA Services Returns to ASQ Space & Defense Forum with Quality Workshop
SQA Services Returns to ASQ Space & Defense Industries Forum with Lifecycle Quality Workshop SQA Services is proud to return as an exhibitor at the ASQ Collaboration on Quality in the Space & Defense Industries Forum, taking place March 10–11 in Cape Canaveral, Florida. The annual event brings together aerospace and defense leaders, quality professionals, […]
Supplier Quality in Aerospace: 9 Strategic Shifts Reshaping the Industry
The conversations at the Generis American Aerospace & Defense Summit revealed a rare level of alignment across primes, Tier-1 suppliers, software providers, startups, and policy-adjacent leaders. One message was unmistakable: Supplier quality in aerospace can no longer be treated as a back-office compliance activity. The industry is being forced to operate at commercial speed, wartime […]
Addressing True Root Cause vs. Contributing Causes in the CAPA Process
In life sciences, a well-executed CAPA (Corrective and Preventive Action) system is one of the strongest indicators of a mature quality organization. Yet one of the most common and costly failures in CAPA execution is the inability to clearly distinguish between contributing causes and the true root cause of a problem. Organizations often invest significant […]
Capability Assessment in Aerospace: Ensuring Readiness for High-Rate Production
As aerospace programs transition from development into high-rate production, the margin for error narrows dramatically. Aircraft platforms, space systems, and defense programs require not only flawless quality but repeatable performance at scale. A single late delivery or nonconforming part can disrupt schedules, inflate costs, and erode customer confidence across the supply chain. This is where […]
SQA Regulatory Surveillance Summary for Q2 2025 | Pharmaceutical Regulatory News
This edition of the pharmaceutical regulatory news summary highlights key global developments impacting pharmaceuticals, medical devices, and compliance. The update covers enforcement actions, safety alerts, and regulatory guidance issued by major health authorities including ANVISA, FDA, EMA, NMPA, MHRA, Health Canada, WHO, and others, offering timely insight into evolving regulatory expectations worldwide.